The pooled OR from 3 studies involving blood samples from 295 patients with CRC and 127 healthy subjects showed that methylated SFRP2 had a similar OR in CRC and healthy subjects (P = 0.055) (Fig. 5). Here, SFRP2 is linked to colorectal carcinoma.